Journals / Trakya Üniversitesi Tıp Fakültesi Dergisi / 2007 / Cilt: 24 - Sayı: 3

Malign melanomların klinik ve histopatolojik özellikleri

The clinical and histopathological characteristics of cutaneous malignant melanoma

Pages
228–234
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The complications and benefits must be meticulously evaluated before application of lymph-node dissection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The most effective method of treatment of cutaneous malignant melanoma (CMM) is surgical excision performed in the early stages.
📊
Key Findings & Data:Patients and Methods: Fifty-five patients with malignant melanoma (32 males, 23 females; mean age 50.9±12.9; years, range 26 to 76 years) were evaluated retrospectively.
💡
Conclusion & Impact:The complications and benefits must be meticulously evaluated before application of lymph-node dissection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lenf düğümü çıkartılması · Melanom · Geriyedönük çalışma

Abstract

The most effective method of treatment of cutaneous malignant melanoma (CMM) is surgical excision performed in the early stages. Our aim was to evaluate the descriptive characteristics of CMM. Patients and Methods: Fifty-five patients with malignant melanoma (32 males, 23 females; mean age 50.9±12.9; years, range 26 to 76 years) were evaluated retrospectively. Surgical excision alone was performed on stage I and II patients. Regional lymph-node dissection was performed together with surgical excision on patients with palpabl lymph nodes (stages III and IV) detected during preoperative examination. Descriptive characteristics such as anatomical locations, histological subtypes and stages of the CMM were examined; the tumor size and thickness, adjuvant chemotherapy and immunotherapy rates, local recurrence rates were evaluated. Results: Palpabl lymph nodes were identified in 74% (n=41) of the patients. Lymph-node dissection was performed together with surgical excision on these patients. The average tumor thickness and tumor size were 2.1±1.3 mm and 21.7±11.6 mm respectively. Conclusion: Width of surgical margins and wide surgical resection with lymph-node dissection for CMM will have no effect on loco-regional recurrence, distant metastases and survival rates. The complications and benefits must be meticulously evaluated before application of lymph-node dissection.

Özet

Deri malign melanomlarının en etkili tedavi yöntemi erken dönemde yapılacak cerrahi eksizyondur. Bu çalışmada malign melanomun tanımlayıcı özelliklerinin saptanması amaçlandı. Hastalar ve Yöntemler: Malign melanom saptanan 55 hastanın (32 erkek, 23 kadın; ort. yaş 50.9±12.9; dağılım 26-76) dosyaları geriye dönük olarak incelendi. Evre I ve evre II hastalara yalnızca cerrahi eksizyon yapıldı. Ameliyat öncesi dönemde palpabl lenf nodu tespit edilen evre-III ve evre-IV hastalarda cerrahi eksizyonla birlikte bölgesel lenf nodu diseksiyonu yapı ldı. Malign melanomların yerleşim yerleri, histolojik alt türleri ve evreleri gibi tanımlayıcı özellikleri incelendi; tümör çapı ve derinliği, yardımcı kemoterapi ve immünoterapi oranları, lokal yineleme oranları değerlendirildi. Bulgular: Kırk bir hastada (%74) palpabl lenf nodu tespit edildi. Bu hastalara cerrahi eksizyonla birlikte bölgesel lenf nodu diseksiyonu yapıldı. Ortalama tümör çapı 21.7±11.6 mm, tümör derinliği ise 2.1±1.3 mm bulundu. Sonuç: Cerrahi sınırların genişliği ve lenf nodu diseksiyonu ile lokal yineleme, uzak metastazlar ve yaşam süresi arasında anlamlı bir ilişki olmadığı saptandı. Bölgesel lenf nodu diseksiyonu yapmaya karar verirken diseksiyondan beklenen yararlar ve olası komplikasyonlar göz önünde bulundurularak karar verilmelidir.

🔖

Cite This Article

ÇÖL, C., TUNÇ, G., YANDAKÇI, K., HASDEMİR, O., YALÇIN, E. (2007). Malign melanomların klinik ve histopatolojik özellikleri. Trakya Üniversitesi Tıp Fakültesi Dergisi, Cilt: 24 - Sayı: 3, 228–234. https://ajindex.com/articles/369711

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Vandaele MM, Richert B, Van der Endt JD, Boyden B, Brochez L, del Marmol V, et al. Melanoma screening: results of the first one-day campaign in Belgium (‘melanoma Monday’). J Eur Acad Dermatol Venereol 2000;14:470-2
  2. Loria D, Matos E. Risk factors for cutaneous melanoma: a case-control study in Argentina. Int J Dermatol 2001;40:108-14
  3. Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001;44:837-46
  4. Rossi CR, Foletto M, Vecchiato A, Alessio S, Menin N, Lise M. Management of cutaneous melanoma M0: state of the art and trends. Eur J Cancer 1997;33:2302-12
  5. Lang PG Jr. Malignant melanoma. Med Clin North Am 1998;82:1325-58
  6. Glass FL, Cottam JA, Reintgen DS, Fenske NA. Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. J Am Acad Dermatol 1998;39:603-10
  7. Olhoffer IH, Bolognia JL. What's new in the treatment of cutaneous melanoma? Semin Cutan Med Surg 1998;17:96-107
  8. Fraker DL. Surgical issues in the management of melanoma. Curr Opin Oncol 1997;9:183-8
  9. Greenstein DS, Rogers GS. Management of stage I malignant melanoma. Dermatol Surg 1995;21:927-37
  10. ECOG 1690. National Cancer Institute. U.S. National Institutes of Health. Available at: http//www.cancer. gov/search/clinical_trials
  11. Ravaud A, Bedane C, Geoffrois L, Lesimple T, Delaunay M. Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice. Br J Cancer 1999;80:1767-9
  12. Chan AD, Essner R, Wanek LA, Morton DL. Judging the therapeutic value of lymph node dissections for melanoma. J Am Coll Surg 2000;191:16-22
  13. Tseng JF, Tanabe KK, Gadd MA, Cosimi AB, Malt RA, Haluska FG, et al. Surgical management of primary cutaneous melanomas of the hands and feet. Ann Surg 1997;225:544-50
  14. Brown M. Staging and prognosis of melanoma. Semin Cutan Med Surg 1997;16:113-21
  15. Vilmer C, Bailly C, Le Doussal V, Lasry S, Guerin P, Delaunay MM, et al. Thin melanomas with unusual aggressive behavior: a report on nine cases. Melanoma Group of French Federation of Cancer Centers. J Am Acad Dermatol 1996;34:439-44
  16. Miliotes G, Albertini J, Berman C, Heller R, Messina J, Glass F, et al. The tumor biology of melanoma nodal metastases. Am Surg 1996;62:81-8
  17. Slingluff CL Jr, Stidham KR, Ricci WM, Stanley WE, Seigler HF. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 pati